Donate

Blog

8 Reasons Why Insulin is so Outrageously Expensive

8 Reasons Why Insulin is so Outrageously Expensive

Why does insulin cost so much to patients in the USA and around the world? Why is insulin, a widely sold drug of which most forms are now off-patent, so incredibly expensive? These are simple questions, but ones with a number of complicated answers. This post will break some of those answers down and point you in the direction further reading if you want to dive deeper. Read more

T1International Statement on Novo Nordisk and Sanofi Price Hikes

T1International Statement on Novo Nordisk and Sanofi Price Hikes

Sanofi and Novo Nordisk are celebrating the New Year with fresh price hikes on their decades-old insulin products. “Sanofi increased the price of its three main insulin brands by between 4.4 %- 5.2 % last week, while Novo Nordisk increased the price of its insulin products by just under 5% on Tuesday,” the Financial Times article said. Once again, shareholder profits will be increased on the backs of people with diabetes. Read more

Finding Hope, Despite Fear

Finding Hope, Despite Fear

Volunteering for T1International was my greatest accomplishment in 2018. It has been therapeutic in accepting my diagnosis, even if it is 7 years late. Advocating for myself and those like me is healing. Read more

Hoosiers with Diabetes Petition Indiana General Assembly to Study Drug Pricing

Hoosiers with Diabetes Petition Indiana General Assembly to Study Drug Pricing

Hoosiers living with Type 1 diabetes today delivered to the Indiana General Assembly a petition signed by over 500 persons demanding that the House Public Health Committee hear a bill to establish a study committee on rising prescription drug prices. The petition was delivered to House of Representatives Public Health Committee Chair Rep. Cindy Kirchofer and all of the committee members. Read more

T1International Year in Review: 2018

T1International Year in Review: 2018

This is truly only a highlight of our proudest achievements this year, but we have worked in countless other ways to support advocacy and further our mission. We’ve held other meetings, created new resources, covered issues in new countries, been featured as Price fighting Heroes, and we are a partner in the exciting OPEN Project, adding a global access and affordability perspective to an exploration of DIY technology. Read more

T1International Names Nicole Smith-Holt Charity Ambassador

T1International Names Nicole Smith-Holt Charity Ambassador

T1International is proud and honoured to announce that Nicole Smith-Holt as accepted our invitation to serve as T1International Charity Ambassador. Read more

Necessary Baggage: Lessons Learned in Senegal

Necessary Baggage: Lessons Learned in Senegal

It took experiencing a situation where the healthcare available felt scarily inadequate to truly internalize the medical privilege I have enjoyed throughout my life. My time in Senegal put the hardship of diabetes in perspective and helped me truly appreciate the resources that I have. Read more

Lack of Knowledge about Diabetes is Killing us

Lack of Knowledge about Diabetes is Killing us

For me, I hid myself for more than 10 years. I would have rather died than have someone find out I was diabetic. I did that because of misinterpretations from many people due to lack of knowledge about it. I had to tell my mom that no one should know that I’m diabetic unless it was necessary. As a result, those few who knew came up with a lot of their own interpretations about it. I was told many times that traditional herbs would cure me completely. Obviously, none of those worked and I am still diabetic today. Read more

World Diabetes Day 2018

World Diabetes Day 2018

It is World Diabetes Day (WDD), which is the highlight of Diabetes Awareness Month. We asked our supporters if this month was a time of celebration or mourning. Most chose celebration, but quite a few chose mourning. It was a bit of a trick question to be honest, as most of us will have a mix of emotions today.
Read more

Sanofi's Lantus is Overpatented and Overpriced

Sanofi's Lantus is Overpatented and Overpriced

The diabetes community knows the sting of high drug prices. Over the years, the prices of essential insulin has increased at an alarming rate, requiring patients to jump through higher hoops and make more difficult decisions to keep up with costs. But how did we reach the point where so many people with diabetes cannot afford the medicines they need? Our new report on Lantus may provide some insight. Read more